The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Open accessAbstract
For more than 60 years, the mood stabilizer lithium has been used alone or in combination for the treatment of bipolar disorder, schizophrenia, depression, and other mental illnesses. Despite this long history, the molecular mechanisms trough which lithium regulates behavior are still poorly understood. Among several targets, lithium has been shown to directly inhibit glycogen synthase kinase 3 alpha and beta (GSK3α and GSK3β). However in vivo, lithium also inhibits GSK3 by regulating other mechanisms like the formation of a signaling complex comprised of beta-arrestin 2 (βArr2) and Akt. Here, we provide an overview of in vivo evidence supporting a role for inhibition of GSK3 in some behavioral effects of lithium. We also explore how regulation of GSK3 by lithium within a signaling network involving several molecular targets and cell surface receptors [e.g., G protein coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs)] may provide cues to its relative pharmacological selectivity and its effects on disease mechanisms. A better understanding of these intricate actions of lithium at a systems level may allow the rational development of better mood stabilizer drugs with enhanced selectivity, efficacy, and lesser side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Self-citationA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT
Cade, J. F. J. (1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb36912.x · Cited by 1,463
Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,410
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Lithium salts in the treatment of psychotic excitement
Cade, J. F. J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,150
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,014
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Self-citationRole of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 1×
“…surface receptors including several G protein coupled receptors (GPCRs) and most receptor tyrosine kinases (RTKs) have been shown to be involved in the activation of Akt isoforms via PI3K mediated signaling (Lemmon and Schlessinger, 2010; Liao and Hung, 2010; Beaulieu, 2011; Swift et al., 2011).”
BackgroundBeaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
Self-citationMao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., Tassa, C., Berry, E. M., Soda, T., Singh, K. K., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.044 · Cited by 774
Mechanism of activation and function of protein kinase B
Alessi, D. R., & Cohen, P. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80062-2 · Cited by 743
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., & Woodgett, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05715.x · Cited by 629
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Cipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1805 · Cited by 617
PKB/AKT: functional insights from genetic models
Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 609
Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., & Kennedy, J. L. (2002) · The American Journal of Human Genetics · doi:10.1086/342288 · Cited by 594
Mitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation
Stambolic, V, & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
(1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.197 · Cited by 556
THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTS
Schou, M., Juel-Nielsen, N., Stromgren, E., & Voldby, H. (1954) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.17.4.250 · Cited by 552
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Self-citationMolecular Targets of Lithium Action
Phiel, C. J., & Klein, P. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 515
Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493
Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S., & Kikuchi, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10823 · Cited by 491
GSK-3: Functional Insights from Cell Biology and Animal Models
Kaidanovich-Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 485
Behavioral phenotyping strategies for mutant mice
Crawley, J. N. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.001 · Cited by 439
Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium
Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 435
O'Brien, W. T., Harper, A. D., Jové, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415
Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
Schmidt, H. D., & Duman, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.114 · Cited by 403
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders
Dé Montigny, C., Grunberg, F., Mayer, A., & Deschenes, J.-P. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.3.252 · Cited by 367
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Self-citationMasri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320
Self-citationJaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N. J., & Sawa, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.007 · Cited by 319
Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
Eldar-Finkelman, H., & Krebs, E. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9660 · Cited by 319
Law, A. J., Kleinman, J. E., Weinberger, D. R., & Weickert, C. S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl449 · Cited by 306
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300
PARKER, P. J., CAUDWELL, F. B., & COHEN, P. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07140.x · Cited by 298
A Chaperone-Dependent GSK3β Transitional Intermediate Mediates Activation-Loop Autophosphorylation
Lochhead, P. A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N., & Cleghon, V. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.009 · Cited by 283
Judging a Protein by More Than Its Name: GSK-3
Woodgett, J. R. (2001) · Science's STKE · doi:10.1126/stke.2001.100.re12 · Cited by 279
Kaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276
Kvajo, M., McKellar, H., Arguello, P. A., Drew, L. J., Moore, H., MacDermott, A. B., Karayiorgou, M., & Gogos, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802615105 · Cited by 268
Sutherland, C., & Cohen, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80112-6 · Cited by 238
Beaulieu, J.-M. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110011 · Cited by 238
Self-citationIn Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
Gould, T. D., Chen, G., & Manji, H. K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300283 · Cited by 217
Mines, M. A., Yuskaitis, C. J., King, M. K., Beurel, E., & Jope, R. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009706 · Cited by 208
Benedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195
Trends in the Treatment of Bipolar Disorder by Outpatient Psychiatrists
Blanco, C., Laje, G., Olfson, M., Marcus, S. C., & Pincus, H. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1005 · Cited by 192
Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?
Rapoport, S. I., & Bosetti, F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.592 · Cited by 188
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 176
GSK3 and Alzheimer’s disease: facts and fiction…
Kremer, A., Louis, J. V., Jaworski, T., & Leuven, F. V. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00017 · Cited by 175
Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Beaulieu, J.-M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 160
Self-citationSignaling networks in the pathophysiology and treatment of mood disorders
Gould, T. D., & Manji, H. K. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00426-9 · Cited by 144
O’Brien, W. T., Huang, J. Y., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., & Klein, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45194 · Cited by 123
AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice
Pan, J. Q., Lewis, M. C., Ketterman, J. K., Clore, E. L., Riley, M. M., Richards, K. R., Berry-Scott, E., Liu, X., Wagner, F. F., Holson, E. B., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.24 · Cited by 115
Adli, M., Hollinde, D. L., Stamm, T. J., Wiethoff, K., Tsahuridu, M., Kirchheiner, J., Heinz, A., & Bauer, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.023 · Cited by 111
Li, X., Friedman, A. B., Zhu, W., Wang, L., Boswell, S., May, R., Davis, L. L., & Jope, R. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.027 · Cited by 111
Swift, J. L., Godin, A. G., Doré, K., Freland, L., Bouchard, N., Nimmo, C. M., Sergeev, M., Koninck, Y. D., Wiseman, P. W., & Beaulieu, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018280108 · Cited by 89
Self-citationA molecular mechanism for the effect of lithium on development
Klein, P. S., & Melton, D. A. (2019) · Routledge eBooks · doi:10.4324/9781315054308-24 · Cited by 88
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients
Tondo, L., & Baldessarini, R. J. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00000439 · Cited by 87
Looking at Lithium: Molecular Moods and Complex Behaviour
Beaulieu, J., & Caron, M. G. (2008) · Molecular Interventions · doi:10.1124/mi.8.5.8 · Cited by 86
Self-citationBlasi, G., Napolitano, F., Ursini, G., Taurisano, P., Romano, R., Caforio, G., Fazio, L., Gelao, B., Giorgio, A. D., Iacovelli, L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013535108 · Cited by 85
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
Valenstein, M. M., McCarthy, J. F., Austin, K. L., Greden, J. F., Young, E. A., & Blow, F. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.7.1219 · Cited by 69
The Impact of Lithium Long-Term Medication on Suicidal Behavior and Mortality of Bipolar Patients
Müller-Oerlinghausen, B., Felber, W., Berghöfer, A., Lauterbach, E., & Ahrens, B. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929550 · Cited by 68
IMPA1 is Essential for Embryonic Development and Lithium-Like Pilocarpine Sensitivity
Cryns, K., Shamir, A., Acker, N. V., Levi, I., Daneels, G., Goris, I., Bouwknecht, J. A., Andries, L. J., Kass, S. U., Agam, G., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301431 · Cited by 68
LITHIUM AND MAGNESIUM-DEPENDENT ENZYMES
Birch, N. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91187-8 · Cited by 57
Efficacy of lithium in mania and maintenance therapy of bipolar disorder.
Bowden, C. L. (2000) · PubMed · Cited by 56
Serretti, A., Benedetti, F., Mandelli, L., Calati, R., Caneva, B., Lorenzi, C., Fontana, V., Colombo, C., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.017 · Cited by 51
Waraich, R. S., Weigert, C., Kalbacher, H., Hennige, A. M., Lutz, S. Z., Häring, H., Schleicher, E. D., Voelter, W., & Lehmann, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708588200 · Cited by 50
Lack of Lithium-Like Behavioral and Molecular Effects in IMPA2 Knockout Mice
Cryns, K., Shamir, A., Shapiro, J., Daneels, G., Goris, I., Craenendonck, H. V., Straetemans, R., Belmaker, R. H., Agam, G., Moechars, D., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301154 · Cited by 46
Shaldubina, A., Johanson, R. A., O’Brien, W. T., Buccafusca, R., Agam, G., Belmaker, R. H., Klein, P. S., Bersudsky, Y., & Berry, G. T. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.03.007 · Cited by 36
Alteration of Lithium Pharmacology through Manipulation of Phosphoadenosine Phosphate Metabolism
Spiegelberg, B. D., Cruz-Racelis, J. D., Law, T.-H., & York, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407890200 · Cited by 33
Liberman, Z., Plotkin, B., Tennenbaum, T., & Eldar-Finkelman, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00050.2008 · Cited by 31
(2010) · PubMed Central
Cited by
Potential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Wnt Pathway in Bone Repair and Regeneration – What Do We Know So Far
Houschyar, K. S., Tapking, C., Borrelli, M. R., Popp, D., Duscher, D., Maan, Z. N., Chelliah, M. P., Li, J., Harati, K., Wallner, C., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00170 · Cited by 295
Liu, R.-J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.128 · Cited by 256
“This inhibition can occur in two ways: directly by antagonizing Mgþþ and indirectly through activation of the serine/threonine kinase Akt upstream from mTOR (Freland and Beaulieu, 2012) and lithium destabilization of a b-arrestin/Akt/PP2A/GSK-3 complex (Jope, 2011).”
BackgroundAntidepressant therapies inhibit inflammation and microglial M1-polarization
Kalkman, H. O., & Feuerbach, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.001 · Cited by 212
Metadata
- Authors
- Freland, L., & Beaulieu, J.-M.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 5
- Pages
- 14-14
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2041013746
- Cited by
- 269
- References
- 87
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.